SK12894A3 - Aminoascorbes acid derivatives, method of preparation and their using - Google Patents
Aminoascorbes acid derivatives, method of preparation and their using Download PDFInfo
- Publication number
- SK12894A3 SK12894A3 SK128-94A SK12894A SK12894A3 SK 12894 A3 SK12894 A3 SK 12894A3 SK 12894 A SK12894 A SK 12894A SK 12894 A3 SK12894 A3 SK 12894A3
- Authority
- SK
- Slovakia
- Prior art keywords
- group
- formula
- carbon atoms
- hydrogen
- benzyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/66—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HR930131A HRP930131A2 (en) | 1993-02-05 | 1993-02-05 | Amino-ascorbic acid derivatives, process for the preparation and use thereof |
| JP6013667A JPH07101950A (ja) | 1993-02-05 | 1994-02-07 | アミノ−アスコルビン酸誘導体、その製造法及び用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK12894A3 true SK12894A3 (en) | 1994-12-07 |
Family
ID=26316867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK128-94A SK12894A3 (en) | 1993-02-05 | 1994-02-04 | Aminoascorbes acid derivatives, method of preparation and their using |
Country Status (11)
| Country | Link |
|---|---|
| EP (3) | EP0609899A1 (bg) |
| JP (1) | JPH07101950A (bg) |
| CN (1) | CN1099753A (bg) |
| BG (1) | BG62167B1 (bg) |
| CA (1) | CA2114970C (bg) |
| CZ (1) | CZ24594A3 (bg) |
| HR (1) | HRP930131A2 (bg) |
| HU (1) | HUT71606A (bg) |
| PL (1) | PL302144A1 (bg) |
| SI (1) | SI9400061A (bg) |
| SK (1) | SK12894A3 (bg) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4980911B2 (ja) | 2005-01-25 | 2012-07-18 | パナソニック株式会社 | 電源システム |
| KR101119027B1 (ko) * | 2009-05-07 | 2012-03-14 | (주)코스몰 | 아스코르빈산 유도체의 제조방법 |
| JP2013230984A (ja) * | 2010-08-19 | 2013-11-14 | Seiwa Kasei Co Ltd | アスコルビン酸由来組成物、その製造方法、及び化粧料 |
| JP6872548B2 (ja) | 2015-12-03 | 2021-05-19 | スリーエム イノベイティブ プロパティズ カンパニー | 光解離性還元剤を有するレドックス重合性組成物 |
| CN118480032A (zh) * | 2021-04-30 | 2024-08-13 | 禾美生物科技(浙江)有限公司 | 抗坏血酸多肽衍生物及其制备方法和应用 |
| CN114369075B (zh) * | 2022-02-14 | 2023-09-29 | 河北乐开节能科技股份有限公司 | 利用2-酮基-l-古龙酸的水溶液一步制备vc结晶的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2616351A1 (de) * | 1975-05-03 | 1976-11-11 | Hoffmann La Roche | Halogenderivate |
| US4440738A (en) * | 1982-06-10 | 1984-04-03 | Mallinckrodt, Inc. | Stable radiographic imaging agents |
| US4504462A (en) * | 1982-06-10 | 1985-03-12 | Mallinckrodt, Inc. | Process for making a lyophilized product for use in skeletal imaging |
| EP0446539A1 (en) * | 1990-03-16 | 1991-09-18 | Merrell Dow Pharmaceuticals Inc. | Novel ascorbic acid derivatives |
-
1993
- 1993-02-05 HR HR930131A patent/HRP930131A2/xx not_active Application Discontinuation
-
1994
- 1994-02-04 BG BG98438A patent/BG62167B1/bg unknown
- 1994-02-04 EP EP94101742A patent/EP0609899A1/en not_active Withdrawn
- 1994-02-04 EP EP97106486A patent/EP0791587A1/en not_active Withdrawn
- 1994-02-04 CA CA002114970A patent/CA2114970C/en not_active Expired - Fee Related
- 1994-02-04 PL PL94302144A patent/PL302144A1/xx unknown
- 1994-02-04 CZ CZ94245A patent/CZ24594A3/cs unknown
- 1994-02-04 SK SK128-94A patent/SK12894A3/sk unknown
- 1994-02-04 EP EP97106487A patent/EP0791588A1/en not_active Withdrawn
- 1994-02-04 HU HU9400325A patent/HUT71606A/hu unknown
- 1994-02-04 SI SI9400061A patent/SI9400061A/sl unknown
- 1994-02-05 CN CN94102746A patent/CN1099753A/zh active Pending
- 1994-02-07 JP JP6013667A patent/JPH07101950A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1099753A (zh) | 1995-03-08 |
| BG62167B1 (bg) | 1999-04-30 |
| HUT71606A (en) | 1996-01-29 |
| CA2114970A1 (en) | 1994-08-06 |
| HRP930131A2 (en) | 1997-02-28 |
| CZ24594A3 (en) | 1994-08-17 |
| BG98438A (bg) | 1994-09-30 |
| EP0791588A1 (en) | 1997-08-27 |
| SI9400061A (en) | 1994-09-30 |
| CA2114970C (en) | 1999-06-22 |
| HU9400325D0 (en) | 1994-05-30 |
| EP0609899A1 (en) | 1994-08-10 |
| JPH07101950A (ja) | 1995-04-18 |
| EP0791587A1 (en) | 1997-08-27 |
| PL302144A1 (en) | 1994-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gibson et al. | Selective removal of an N-BOC protecting group in the presence of a tert-butyl ester and other acid-sensitive groups | |
| Sauers | Dehydration of N-arylmaleamic acids with acetic anhydride | |
| Greenberg et al. | Structure and dynamics of Troeger's base and simple derivatives in acidic media | |
| SU784783A3 (ru) | Способ получени производных лейрозидина или их солей | |
| EP0277588A1 (en) | Prolinal derivatives | |
| BG60999B1 (en) | Method for the preparation of clavulanic acid | |
| SK12894A3 (en) | Aminoascorbes acid derivatives, method of preparation and their using | |
| IL295197B2 (en) | Compounds to inhibit fibroblast activation protein | |
| Sakai et al. | Synthesis and DNA binding of [3-[2'-(2-acetamidoethyl)-2, 4'-bithiazole-4-carboxamido] propyl] dimethylsulfonium chloride, a fragment of bleomycin A2 | |
| FI65998B (fi) | Foerfarande foer framstaellning av nya farmakologiskt aktiva pyrrolyl-pyridazinaminderivat | |
| GB2052484A (en) | Epoxysuccinyl amino acid derivatives | |
| IE46983B1 (en) | Fluorinated amino acids | |
| US5627194A (en) | Anti-viral guanidino-substituted compounds | |
| RU2079489C1 (ru) | Стабильные соли (+)-(1s,2r)-2[[n-(2-гидроксиамино-2-оксоэтил)-n-метиламино]-карбонил]циклогексан-1-карбоновой кислоты, способ их получения и фармацевтическая композиция | |
| US5559251A (en) | Derivatives of amino-ascorbic acid, the processes for their preparation and use | |
| EP0137742B1 (en) | Process for producing arginyl-p-nitroanilide | |
| CA1196342A (en) | Process for preparing benzylalcohol derivatives | |
| JP2681369B2 (ja) | ベンゾトリアゾール誘導体およびそれを含有するカルボン酸類分析用試薬 | |
| PT915858E (pt) | Intermediarios para a preparacao de 2-imidazolina-5-onas | |
| US4649222A (en) | 2-(substituted amino)-2-[2-hydroxy-2-alkyl (or phenyl)ethyl]tricyclo[3.3.1.13,7 ]decane hydrohalides | |
| RU2126398C1 (ru) | Производные аминоаскорбиновой кислоты, способы их получения и производные галоидаскорбиновой кислоты | |
| US5106846A (en) | 2,3-thiomorpholinedione-2-oxime derivatives and pharmaceutical compositions containing them | |
| BG62520B1 (bg) | Аналози на аргинина, притежаващи инхибираща активност върхуno-синтетазата | |
| CA2188452C (en) | Guanidino-substituted compounds | |
| Mokotoff et al. | Potential inhibitors of L-asparagine biosynthesis. 3. Aromatic sulfonyl fluoride analogs of L-asparagine and L-glutamine |